A 51-year-old Afro-Caribbean man presented to the casualty department at the Western Eye Hospital in February 1994 complaining of decreased vision and seeing floaters in the right eye. He had been resident in the United Kingdom since 1961 and 1 month prior to presentation had been on holiday in St Lucia. He had no past eye history and was systemically well. Examination revealed corrected Snellen visual acui ties of 6/6 (R) and 6/5 (L). Fine granulomatous keratic precipitates were present in both eyes scattered throughout the corneal endothelia. There was 1 + of cells and 1 + of flare in both anterior chambers. Intraocular pressures were 10 mmHg (R) and 8 mmHg (L) and dilated fundoscopy revealed no abnormality. A diagnosis of mild granulomatous anterior uveitis was made and he was treated conservatively.
At routine follow-up a month later, Snellen visual acuities were 6/12 (R) and 6/6 (L). Large mutton fat keratic precipitates were now present in both eyes but there was no increase in the cellular activity in the anterior chambers. A few cells were present in the right anterior vitreous. Full blood count, ery throcyte sedimentation rate (ESR), serum angioten sin converting enzyme and treponemal serology were all normal and a plain chest radiograph revealed no abnormality. He was started on guttae betamethasone t.d.s. to both eyes. A month later at a routine clinic visit the visual acuities were 6/6 in both eyes. The keratic precipitates had resolved and no abnormalities were found in the anterior or posterior chambers. The course of topical steroid drops was reduced over 4 weeks and he was discharged from the clinic.
The first symptoms of HAM developed 3 months later with urinary retention, constipation and pro gressive paraparesis. Human T-cellieukaemia/lym phoma virus type IIII infection was diagnosed by the detection of serum and cerebrospinal fluid anti HTL V antibodies in high titre by Fujirebio Serodia HTLV, and this was confirmed and serotyped as HTLV-I by Genelabs HTLV 2.3 WB. HTLV-IIII specific sequences from the HTL V-I tax gene were detected in peripheral blood lymphocytes following amplification by polymerase chain reaction primed with the oligonucleotides SK43/44. He had no further episodes of ocular inflammation until his death from HAM in July 1995. On examination, Snellen visual acuities were 6/9 (R and L). There was a mild right ciliary injection and 1 + of cells and flare in the right anterior chamber. Early nuclear sclerotic lens opacities were noted. No abnormalities were found in the vitreous or retina. A. diagnosis of mild acute right anterior uveitis was made. She was treated with topical guttae betamethasone q.d. s. and guttae cyclopentolate t.d.s. to the right eye. Full blood count, ESR, serum Eye (1996) 10, 521-528 © 1996 Royal College of Ophthalmologists angiotensin converting enzyme and treponemal serology were all normal and a chest radiograph revealed no abnormality. Two weeks later the uveitis had cleared and the drops were reduced over 2 weeks. She had suffered no similar episodes 9 months later.
Discussion
HTL V -1 infection is strongly linked to the subse quent development of adult T-cell leukaemia/lym phoma and HTLV-I associated myelopathy (HAM), which is also referred to as tropical spastic parapar esis (TSP). It is also associated with other inflamma tory conditions but causes asymptomatic lifelong infection in the majority of individuals. 1 -3 Ocular manifestations associated with HTL V-I infection have been documented, particularly in Japan, and include a steroid-resistant vasculitis 4 and a granu lomatous or non-granulomatous uveitis. 5 However, the exact role of HTL V-I in the pathogenesis of these disorders remains uncertain. 6 In keeping with previous reports, our patients' anterior uveitides resolved completely with topical steroids. However, the development in case 1 of HAM 3 months after the initial presentation is in contrast with the results of a recent study of 32 patients with HTLV-I associated uveitis in which no patient developed neurological disease. Anterior uveitis has been described in patients with pre existent HAMITSP ?
HTL V-I is endemic in Japan, the Caribbean, Melanesia, Central Africa and parts of Central and South America, and in peoples who have migrated from these regions. Thus amongst the Afro-Carib bean community in the United Kingdom, the prevalence of HTLV-I is 2%, 8 although its preva lence in those with uveitis is unknown. The infection may be acquired by vertical transmission, as in case 2, and this emphasises the importance of a family history in the diagnosis and counselling of patients found to be HTLV-I positive.
Although the cause of uveitis in these two cases was ascribed to HTLV-I infection without intra ocular biopsy, they highlight the need to consider HTLV-I infection in patients belonging to at-risk groups who present with uveitis of unknown aetiol ogy, and the need for further studies into the prevalence of positive HTL V -I serology in such patients. Calcium deposition in the cornea is usually the result of long-standing ocular disease but may also be associated with underlying hypercalcaemia. Occa sionally, corneal deposits may be the presenting sign of an underlying disorder of calcium and phosphate metabolism which may occur with hyperparathyroid ism, sarcoidosis, chronic renal failure and hypervita minosis D. 1,2
Lipid deposition occurs in scarred vascular cor neas; however, primary lipid keratopathy may be a manifestation of underlying hyperlipidaemia ? . 4 Crys talline corneal deposits have been described in association with m ultiple myeloma 5 and streptococ cal infections of the cornea. 6 A case in which corneal deposits were the presenting sign of both hyperparathyroidism and hyperlipidaemia is discussed. The recurrence and
